Search Results for

Bijan Amirghassemi, MD

Medical School: University of Azarabadegan, Iran
Residency: St. Louis Hospital, Paris, France, Inova Fairfax Hospital
Board Certification: Anatomic Pathology, Clinical Pathology
Fellowship Training: Anatomic Pathology – Armed Forces Institute of Pathology
Location: Raleigh General Hospital, Beckley, West Virginia
Phone: 615-562-9200
Email: bamirghassemi@pathgroup.com

Michael I. Argyres, MD

Medical School: Medical College of Wisconsin, MD
Residency: University of Colorado
Board Certification: Anatomic Pathology, Clinical Pathology
Fellowship Training: Stanford University
Location: Valley Health – Winchester Medical Center – Winchester, VA
Email: miargyres@pathgroup.com

Diana Castro-Villabon, MD

Medical School: Universidad de los Andes
Residency: Rutgers – New Jersey Medical School
Board Certification: Anatomic Pathology, Clinical Pathology
Fellowship Training: Zucker School of Medicine at Hofstra/Northwell, University of Florida College of Medicine
Location: Baptist Memorial Hospital – East, Memphis, TN
Email: dpcastrovillabon@pathgroup.com

Lili Geng, MD

Medical School: Medical College of Qingdao University
Residency: Drexel College of Medicine
Board Certification: Anatomic Pathology, Clinical Pathology, Hematopathology, Cytopathology
Fellowship Training: Wayne State School of Medicine
Location: Lutheran Hospital – Fort Wayne, IN
Email: ligeng@pathgroup.com

Vaginal Health Portfolio

VHP Banner

BV+ Report - FINAL

PathGroup’s new Vaginal Health Portfolio utilizes the most advanced PCR technology, providing accurate and actionable answers in less time for the most common infections of the genital tract. And with a dedicated panel for Bacterial Vaginosis, you’ll gain valuable insights into your patient’s vaginal ecosystem for more targeted and effective management.

PathGroup’s Vaginal Health Portfolio is comprised of tailored, infection-specific panels providing clinically relevant and actionable results for:

  • Bacterial Vaginosis+
  • Candida
  • Leukorrhea
  • Vaginitis
  • Aerobic Vaginitis
  • STI/STD
  • Genital Ulcer

Early & Accurate Detection

  • Industry leading turnaround times
  • 31 organisms providing superior sensitivity and specificity
  • Clinically relevant, infection-specific panels
  • Single sample, convenient collection

In-Network Strategy

  • All insurances accepted – preferred provider status with an extensive payer list
  • Over 98% of claims are processed in-network annually
  • Meaningful, cost-conscience test utilization

Innovative Technology, Actionable Results

  • Tailored, clinically relevant panels focused on key infectious organisms
  • Advanced PCR technology for quantitative results
  • Straightforward reports with simple informatics and clinically actionable data
  • HL7-compliant reports for ease of use and interpretation

 

To partner with PathGroup, call 800.366.5847 or email marketing@pathgroup.com for more information.

Taylor L. Hartley, MD, MPH

Medical School: Texas Tech University
Residency: University of Texas, University of Minnesota
Board Certification: Anatomic Pathology, Clinical Pathology, Cytopathology
Fellowship Training: Hematopathology – University of Texas
Fellowship Training: Cytopathology – University of Texas
Specialty: Hematopathology, Cytopathology
Location: Grassmere Laboratory, Nashville, Tennessee
Phone: 615-562-9200
Email: thartley@pathgroup.com

Frances L. Cate, MD

Medical School: Medical University of South Carolina
Residency: Vanderbilt University Medical Center
Board Certification: Anatomic Pathology, Clinical Pathology
Fellowship Training: Cytopathology – Vanderbilt University Medical Center
Specialty: Cytopathology
Location: PathGroup Laboratory, Nashville, Tennessee
Phone: 615-562-9200
Email: fcate@pathgroup.com

 

 

 

 

 

ICD-10 Transition

CMS ICD-10 Lookup Tool

2018 ICD-10 Updates

As a reminder, effective October 1, 2017, the 2018 ICD-10-CM updates are in effect (October 1, 2017 through September 30, 2018). Providers should be coding to the highest level of specificity per the 2018 ICD-10-CM updates. If an ICD code is entered that has been updated and/or now requires more specificity, suggestions for a more specific code will be displayed as shown below.

Example of previously valid code:

Z36 Encounter for antenatal screening of mother


Examples of 2018 valid codes within the Z36 category are:

Z36.0 Encounter for antenatal screening for chromosomal anomalies
Z36.1 Encounter for antenatal screening for raised alphafetoprotein level
Z36.2 Encounter for other antenatal screening follow-up

A complete list of the 2018 ICD-10-CM valid codes and code titles is posted on the CMS website at: https://www.cms.gov/Medicare/Coding/ICD10/2018-ICD-10-CM-and-GEMs.html.

ICD-10 Specificity Update

Effective October 1, 2016. Medicare ICD-10 flexibilities have expired. Providers should be coding to the highest level of specificity and also avoiding the use of unspecified ICD-10 codes whenever the clinical documentation supports a more detailed code. If you attempt to use unspecified codes when ordering via PathConnect the order with be rejected.

A complete list of the 2016 ICD-10-CM valid codes and code titles is posted on the CMS website at: https://www.cms.gov/Medicare/Coding/ICD10/2016-ICD-10-CM-and-GEMs.html.

If you have questions about how to code correctly using ICD-10, please visit the Provider Resources section of the CMS ICD-10 website.

Elsie P. Ollapally, MD

Medical School: University of Tennessee Memphis
Residency: Vanderbilt University Medical Center, University of Tennessee Memorial Research Center & Hospital
Retired 2015